Studies on anti-human immunodeficiency virus oligonucleotides that have alternating methylphosphonate/phosphodiester linkages

Pharmacology and Therapeutics

Volumn 85, Issue 3, 2000, Pages 159-163

  Miller, Paul S ^a   Cassidy, Rachel A ^a   Hamma, Tomoko ^a   Kondo, Norman S ^b  

^a Johns H   (United States)

^b UNIVERSITY OF THE DISTRICT OF COLUMBIA   (United States)

Author keywords

Antisense; Binding; HIV; Oligonucleotides; TAR RNA; Triplex

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; COMPLEMENTARY RNA; MAGNESIUM; METHYLPHOSPHONIC ACID; OLIGOMER; OLIGONUCLEOTIDE;

CONFERENCE PAPER; HUMAN IMMUNODEFICIENCY VIRUS; PRIORITY JOURNAL;

BINDING SITES; CELL CULTURE TECHNIQUES; DNA-BINDING PROTEINS; HIV; HUMANS; MODELS, MOLECULAR; NUCLEIC ACID CONFORMATION; OLIGODEOXYRIBONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHORIC ACID ESTERS; RNA, COMPLEMENTARY; RNA, VIRAL;

EID: 0034018927     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(99)00054-6     Document Type: Conference Paper

References (21)

1. Callahan D.E., Trapane T.L., Miller P.S., Ts'o P.O.P., Kan L.-S. Comparative circular dichroism and fluorescence studies of oligodeoxyribonucleotide and oligodeoxyribonucleoside methylphosphonate pyrimidine strands in duplex and triplex formation. Biochemistry. 30:1991;1650-1655.
2. 2O), a dinucleoside monophosphate with neutral phosphodiester backbone. An X-ray crystal study. Nucleic Acids Res. 11:1983;2801-2808.
3. Crooke, S. T., & Lebleu, B. L. (Eds.) (1993). Antisense Research and Applications. Boca Raton: CRC Press.
4. Faruqi A.F., Glazer P.M. Triplex-forming oligonucleotides for genetic manipulation. an alternative view Stein C.A., Krieg A.M. Applied Antisense Oligonucleotide Technology. 1998;487-507 John Wiley & Sons, New York.
5. Froehler B.C., Wadwani S., Terhorst T.J., Gerrard S.R. Oligodeoxynucleotides containing C-5 propyne analogs of 2′-deoxyuridine and 2′-deoxycytidine. Tetrahedron Lett. 33:1992;5307-5310.
6. Hamma T., Miller P.S. Syntheses of alternating oligo-2′-O-methylribonucleoside methylphosphonates and their interactions with HIV TAR RNA. Biochemistry. 38:1999;15333-15342.
7. Inoue H., Hayase Y., Imura A., Iwai S., Miura K., Ohtsuka E. Synthesis and hybridization studies on two complementary nona(2′-O-methyl)ribonucleotides. Nucleic Acids Res. 15:1987;6131-6149.
8. Kean J.M., Cushman C.D., Kang H.M., Leonard T.E., Miller P.S. Interactions of oligonucleotide analogs containing methylphosphonate internucleotide linkages and 2′-O-methylribonucleosides. Nucleic Acids Res. 22:1994;4497-4503.
9. Kean J.M., Kipp S.A., Miller P.S., Kulka M., Aurelian L. Inhibition of herpes simplex virus replication by antisense oligo-2′-O-methylribonucleoside methylphosphonates. Biochemistry. 34:1995;14617-14620.
10. Lesnik E.A., Freier S.M. What affects the effect of 2′-alkoxy modifications? 1. Stabilization effect of 2′-methoxy substitutions in uniformly modified DNA oligonucleotides. Biochemistry. 37:1998;6991-6997.
11. Miller P.S. Development of antisense and antigene oligonucleotide analogs. Moldave K., Cohn W. Progress in Nucleic Acid Research and Molecular Biology. 1995;261-291 Academic Press, San Diego.
12. Miller P.S. Antisense/antigene oligonucleotides. Hecht S. Bioorganic Chemistry. Nucleic Acids:1996;347-374 Oxford University Press, London.
13. Miller P.S. Oligonucleoside methylphosphonates - synthesis and properties. Stein C.A., Krieg A. Applied Oligonucleotide Technology. 1998;3-22 John Wiley & Sons, New York.
14. Miller P.S., Hamma T. Studies on anti-HIV oligonucleotides that contain alternating methylphosphonate/phosphodiester linkages. Antisense Nucleic Acid Drug Dev. 9:1999;367-370.
15. Miller P.S., Dreon N., Pulford S.M., McParland K.B. Oligothymidylate analogues having stereoregular, alternating methylphosphonate/phosphodiester backbones. Synthesis and physical studies. J Biol Chem. 255:1980;9659-9665.
16. Miller P.S., Bi G., Kipp S.A., Fok V., DeLong R.K. Triplex formation by a psoralen-conjugated oligodeoxyribonucleotide containing the base analog 8-oxo-adenine. Nucleic Acids Res. 24:1996;730-736.
17. Miller P.S., Kipp S.A., McGill C. A psoralen-conjugated triplex-forming oligodeoxyribonucleotide containing alternating methylphosphonate - phosphodiester linkages. synthesis and interactions with DNA Bioconjug Chem. 10:1999;572-577.
18. Reynolds M.A., Hogrefe R.I., Jaeger J.A., Schwartz D.A., Riley T.A., Marvin W.B., Daily W.J., Vaghefi M.M., Beck T.A., Knowles S.K., Klem R.E., Arnold L.J. Synthesis and thermodynamics of oligonucleotides containing chirally pure R(P) methylphosphonate linkages. Nucleic Acids Res. 24:1996;4584-4591.
19. Singleton S.F., Dervan P.B. Influence of pH on the equilibrium association constants for oligodeoxyribonucleotide-directed triple helix formation at single DNA sites. Biochemistry. 31:1992;10995-11003.
20. Stein, C. A., & Krieg, A. M. (Eds.) (1998). Applied Antisense Oligonucleotide Technology. New York: John Wiley & Sons.
21. Svinarchuk F., Malvy C. Gene-targeted triple-helix-forming oligonucleotides. Stein C.A., Krieg A.M. Applied Antisense Oligonucleotide Technology. 1998;471-486 John Wiley & Sons, New York.